VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine
- 31 March 2008
- journal article
- research article
- Published by Elsevier BV in Brain, Behavior, and Immunity
- Vol. 22 (3), 318-323
- https://doi.org/10.1016/j.bbi.2007.09.010
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myelomaProceedings of the National Academy of Sciences of the United States of America, 2006
- Norepinephrine Up-regulates the Expression of Vascular Endothelial Growth Factor, Matrix Metalloproteinase (MMP)-2, and MMP-9 in Nasopharyngeal Carcinoma Tumor CellsCancer Research, 2006
- Angiogenesis in multiple myelomaEuropean Journal of Cancer, 2006
- Acetylation and Phosphorylation of High-Mobility Group A1 Proteins in PC-3 Human Tumor CellsBiochemistry, 2006
- Stress Hormone–Mediated Invasion of Ovarian Cancer CellsClinical Cancer Research, 2006
- The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implicationsBlood, 2005
- Vascular endothelial growth factor and social support in patients with ovarian carcinomaCancer, 2002
- Chromosome translocations in multiple myelomaOncogene, 2001
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal TranslocationsJapanese Journal of Cancer Research, 2001
- Psychoneuroimmunology and cancer: fact or fiction?European Journal of Cancer, 1999